https://www.selleckchem.com/pr....oducts/Camptothecine
Combined intradetrusor/intra-augment injections were performed in 11 patients, and the remaining 10 patients received detrusor-only injections. A total of 18 patients (86%) reported subjective improvement with no significant difference associated with site of injection (p=0.59). A total of 17 patients (77%) underwent repeat injections; on average, patients underwent 3.3 injections with interval of 8.8 months between injections. Conclusion BTX-A injection was shown to subjectively improve storage symptoms and continence after augme
Like
Comment
Share
